Identification of a diagnostic model and molecular subtypes of major depressive disorder based on endoplasmic

Shuwen Huang1,2, Yong Li1,2, Jianying Shen1,2

  • 1Research Base of Chinese Medicine Syndrome, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.

Frontiers in Psychiatry
|August 31, 2023
PubMed
Abstract

Insights

This study identifies seven endoplasmic reticulum stress (ERS) genes as novel diagnostic biomarkers for major depressive disorder (MDD), paving the way for precision medicine approaches in MDD diagnosis and treatment.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Major depressive disorder (MDD) presents diagnostic challenges due to its heterogeneity and complex pathology.
  • Endoplasmic reticulum stress (ERS) is implicated in MDD pathogenesis, but diagnostic markers remain underexplored.

Purpose of the Study:

  • To screen for endoplasmic reticulum stress (ERS) genes with potential diagnostic value in major depressive disorder (MDD).
  • To develop and validate a diagnostic model for MDD based on ERS-related genes.

Main Methods:

  • Downloaded gene expression data for MDD from the GEO database.
  • Integrated ERS genes from GeneCards and MSigDB with differentially expressed genes (DEGs) in MDD.
  • Developed and validated an ERS diagnostic model and nomogram using LASSO regression.
  • Identified ERS-associated subtypes and analyzed immune infiltration using CIBERSORT and GSEA.
  • Performed WGCNA to identify hub genes related to ERS molecular subtypes.

Main Results:

  • A diagnostic model was developed using seven ERS genes (KCNE1, PDIA4, STAU1, TMED4, MGST1, RCN1, SHC1) with good diagnostic performance.
  • KCNE1 expression showed correlations with M0 macrophages and resting CD4+ memory T cells.
  • Two MDD subtypes (SubA and SubB) with distinct ER scores and immune infiltration levels were identified.
  • NCF4, NCF2, CSF3R, and FPR2 were identified as hub genes associated with ERS molecular subtypes.

Conclusions:

  • The study identified novel diagnostic biomarkers for MDD from an endoplasmic reticulum stress (ERS) perspective.
  • These findings support the application of precision medicine strategies for MDD diagnosis and management.